Articles/ Views and analysis Healthcare systems aren’t making the most of biosimilars: pharma needs to support them Linda Banks biologics, biosimilars, Celltrion, drug development, IMS Health, Sandoz, Zarxio 0 Comment Biosimilars could save European and US healthcare systems billions – but more needs to be done to maximise Share X Healthcare systems aren’t making the most of biosimilars: pharma needs to support them https://pharmaphorum.com/views-and-analysis/healthcare-systems-aren-t-making-the-most-of-biosimilars-pharma-needs-to-support-them/
News Sandoz bags first-ever biosimilar approval in US Linda Banks biosimilar, Sandoz, Zarxio 0 Comment Novartis generics subsidiary Sandoz made history ahead of the weekend after getting approval in the US for Zarxio, Share X Sandoz bags first-ever biosimilar approval in US https://pharmaphorum.com/news/sandoz-bags-first-ever-biosimilar-approval-in-us/